Dow Down 1.29% Nasdaq Down 3.25%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.57 Down 0.04(2.48%) Feb 5, 4:00PM EST
|After Hours : 1.57 0.00 (0.00%) Feb 5, 4:57PM EST
Prev Close:1.61
Open:1.57
Bid:1.52 x 1000
Ask:1.65 x 700
1y Target Est:5.50
Beta:0.984398
Earnings Date:Feb 29 - Mar 4 (Est.)
Day's Range:1.54 - 1.66
52wk Range:1.30 - 5.12
Volume:2,314,979
Avg Vol (3m):2,889,040
Market Cap:380.80M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 2.48%380.80M
OREXDown 2.65%267.62M
GSKDown 0.54%98.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.45
Quarterly EPS Est (Dec-15) :-0.13
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback